Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugs.

Hernández-Díaz S, García-Rodríguez LA.

Am J Med. 2001 Feb 19;110 Suppl 3A:20S-7S. Review.

PMID:
11173046
3.

Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile.

Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Verma A, Rothman KJ.

Pharmacoepidemiol Drug Saf. 2006 Dec;15(12):861-72.

PMID:
17086563
4.

The hidden cost of nonselective nonsteroidal antiinflammatory drugs in older patients.

Solomon DH, Glynn RJ, Bohn R, Levin R, Avorn J.

J Rheumatol. 2003 Apr;30(4):792-8.

PMID:
12672201
5.
6.

Comparative incidence of upper gastrointestinal bleeding associated with individual non-steroidal anti-inflammatory drugs.

Llorente Melero MJ, Tenías Burillo JM, Zaragoza Marcet A.

Rev Esp Enferm Dig. 2002 Jan;94(1):7-18. English, Spanish.

PMID:
12073673
7.

Application of a propensity score to adjust for channelling bias with NSAIDs.

Morant SV, Pettitt D, MacDonald TM, Burke TA, Goldstein JL.

Pharmacoepidemiol Drug Saf. 2004 Jun;13(6):345-53.

PMID:
15170763
8.
9.

Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population.

Huerta C, Castellsague J, Varas-Lorenzo C, García Rodríguez LA.

Am J Kidney Dis. 2005 Mar;45(3):531-9.

PMID:
15754275
11.

Toxicity of nonsteroidal anti-inflammatory drugs. An overview of the epidemiological evidence.

Carson JL, Willett LR.

Drugs. 1993;46 Suppl 1:243-8. Review.

PMID:
7506183
12.

Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease.

Hernán MA, Logroscino G, García Rodríguez LA.

Neurology. 2006 Apr 11;66(7):1097-9.

PMID:
16606925
13.

[NSAIDs digestive risk: epidemiologic data].

Ravaud P, Chaussade S.

Presse Med. 2003 Nov 22;32(37 Pt 2):S5-8. French.

PMID:
14763348
14.

Nonsteroidal antiinflammatory drugs as a trigger of clinical heart failure.

García Rodríguez LA, Hernández-Díaz S.

Epidemiology. 2003 Mar;14(2):240-6.

PMID:
12606892
15.

The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events.

Hunt RH, Harper S, Watson DJ, Yu C, Quan H, Lee M, Evans JK, Oxenius B.

Am J Gastroenterol. 2003 Aug;98(8):1725-33.

PMID:
12907325
16.

The causes and effects of socio-demographic exclusions from clinical trials.

Bartlett C, Doyal L, Ebrahim S, Davey P, Bachmann M, Egger M, Dieppe P.

Health Technol Assess. 2005 Oct;9(38):iii-iv, ix-x, 1-152. Review.

17.

The role of non-steroidal anti-inflammatory drugs in acute liver injury.

García Rodríguez LA, Pérez Gutthann S, Walker AM, Lueck L.

BMJ. 1992 Oct 10;305(6858):865-8. Erratum in: BMJ 1992 Oct 17;305(6859):920.

18.

Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan.

Sakamoto C, Sugano K, Ota S, Sakaki N, Takahashi S, Yoshida Y, Tsukui T, Osawa H, Sakurai Y, Yoshino J, Mizokami Y, Mine T, Arakawa T, Kuwayama H, Saigenji K, Yakabi K, Chiba T, Shimosegawa T, Sheehan JE, Perez-Gutthann S, Yamaguchi T, Kaufman DW, Sato T, Kubota K, Terano A.

Eur J Clin Pharmacol. 2006 Sep;62(9):765-72. Epub 2006 Jul 4.

PMID:
16821007
20.

Acute upper gastrointestinal bleeding: comparison between recent users and nonusers of nonsteroidal anti-inflammatory drugs.

Adamopoulos A, Efstathiou S, Tsioulos D, Tsami A, Mitromaras A, Mountokalakis T.

Endoscopy. 2003 Apr;35(4):327-32.

PMID:
12664390
Items per page

Supplemental Content

Write to the Help Desk